Search Within

Mark E Robson

Formats
  1. Journal Article (383)
  2. Meeting Abstract (262)
  3. Review (11)
  4. Book Section (7)
  5. Guidelines (7)
  6. Editorial (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (682)
  2. Department of Medicine (682)
  3. Population Sciences Research Program (682)
  4. Solid Tumor Oncology Division (682)
  5. Survivorship Research (682)
  6. GSK Faculty (379)

More Groups

People
  1. Kenneth Offit (280)
  2. Zsofia Stadler (116)
  3. Larry Norton (90)
  4. Vijai Joseph (79)
  5. Diana Mandelker (74)
  6. Michael Berger (67)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (166)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (19)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (188)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Oxford University Press (43)
  6. Elsevier Inc. (42)

More Publishers

Results (682)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
    Journal Article

    Phelan, C. M.; Kuchenbaecker, K. B.; Tyrer, J. P.; Kar, S. P.; Lawrenson, K.; Winham, S. J.; Dennis, J.; Pirie, A.; Riggan, M. J.; Chornokur, G.; more...
    Nature Genetics (2017)

    Fulltext@MSK | Save
  • Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Krammer, J.; Pinker-Domenig, K.; Robson, M. E.; Gönen, M.; Bernard-Davila, B.; Morris, E. A.; Mangino, D. A.; Jochelson, M. S.
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Efficacy and tolerability of veliparib (V; ABT-888) in combination with carboplatin (C) and paclitaxel (P) vs placebo (Plc)+C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer: A randomized, phase 2 study
    Meeting Abstract

    Han, H. S.; Dieras, V.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Evaluation of veliparib (V) and temozolomide (TMZ) in a phase 2 randomized study of the efficacy and tolerability of V plus TMZ or carboplatin (C) and paclitaxel (P) vs placebo (Plc) plus C/P in patients (pts) with BRCA1 or BRCA2 mutations and metastatic breast cancer
    Meeting Abstract

    Dieras, V.; Han, H. S.; Robson, M. E.; Palacova, M.; Marcom, P. K.; Jager, A.; Bondarenko, I.; Citrin, D.; Campone, M.; Telli, M. L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • The landscape of somatic genetic alterations in BRCA1 and BRCA2 breast cancers
    Meeting Abstract

    Geyer, F. C.; Burke, K. A.; Macedo, G. S.; Piscuoglio, S.; Ng, C. K.; Martelotto, L. G.; Papanastatiou, A. D.; De Filippo, M. R.; Schultheis, A. M.; Brogi, E.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • CSMD1 SNPs selectively affect anastrozole response in postmenopausal breast cancer patients
    Meeting Abstract

    Cairns, J.; Ingle, J.; Dudenkov, T.; Kalari, K.; Buzdar, A.; Kubo, M.; Robson, M.; Ellis, M.; Goss, P.; Shepherd, L.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Educational and psychosocial support needs in lynch syndrome: Implementation and assessment of an educational workshop and support group
    Journal Article

    Corines, M. J.; Hamilton, J. G.; Glogowski, E.; Anrig, C. A.; Goldberg, R.; Niehaus, K.; Salo-Mullen, E.; Harlan, M.; Sheehan, M. R.; Trottier, M.; more...
    Journal of Genetic Counseling (2017)

    Fulltext@MSK | Save
  • Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Kuchenbaecker, K. B.; McGuffog, L.; Barrowdale, D.; Lee, A.; Soucy, P.; Dennis, J.; Domchek, S. M.; Robson, M.; Spurdle, A. B.; Ramus, S. J.; more...
    JNCI: Journal of the National Cancer Institute (2017)

    Fulltext@MSK | Save
  • Reply to R.L. Nussbaum et al and J.S. Dolinsky et al
    Journal Article

    Balmaña, J.; Nathanson, K.; Offit, K.; Robson, M.; Domchek, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer
    Journal Article

    Hamilton, J. G.; Genoff, M. C.; Salerno, M.; Amoroso, K.; Boyar, S. R.; Sheehan, M.; Fleischut, M. H.; Siegel, B.; Arnold, A. G.; Salo-Mullen, E. E.; more...
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save